New drug trial aims to halt debilitating heart damage
NCT ID NCT04843020
Summary
This study aimed to see if a new drug called ION-682884 could slow or stop the progression of a serious heart condition called TTR amyloid cardiomyopathy. It was designed for a small group of older patients (65-85 years old) who had already completed a 24-month study with a similar drug. The main goal was to see if long-term treatment could protect the heart by reducing the harmful protein that causes the disease, using heart scans and exercise tests to measure progress.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN AMYLOID CARDIOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.